Deoxythymidylate kinase, DTYMK, is a novel gene for mitochondrial DNA depletion syndrome

Clin Chim Acta. 2019 Sep:496:93-99. doi: 10.1016/j.cca.2019.06.028. Epub 2019 Jul 2.

Abstract

Background: Mitochondrial DNA depletion syndrome is a group of heterogeneous diseases with non-specific presentation. The common feature is the quantitative depletion of mitochondrial DNA without qualitative defects. Diagnosis of these diseases poses a challenge and whole exome sequencing is often needed for their diagnoses.

Case: Two siblings of a quartet family, presenting with hypotonia, microcephaly and severe intellectual disability, have been diagnosed to harbor two heterozygous variants in trans in the DTYMK gene of the thymidine biosynthesis pathway. Mitochondrial DNA depletion has been demonstrated in silico in the more severe sibling.

Conclusions: We suggest the consideration of incorporating DTYMK as one of the associated genes of mitochondrial DNA depletion syndrome (MDDS). DTYMK may be the missing link in the mitochondrial nucleotide salvage pathway but further characterization and additional evidence would be needed.

Keywords: Clinical whole-exome sequencing; DTYMK; Mitochondrial DNA depletion syndrome; Salvage pathway.

Publication types

  • Case Reports

MeSH terms

  • Child
  • DNA, Mitochondrial / genetics
  • DNA, Mitochondrial / metabolism*
  • Exome Sequencing
  • Humans
  • Infant
  • Male
  • Mitochondrial Diseases / enzymology*
  • Mitochondrial Diseases / genetics*
  • Nucleoside-Phosphate Kinase / genetics*
  • Siblings

Substances

  • DNA, Mitochondrial
  • Nucleoside-Phosphate Kinase
  • dTMP kinase